Derma Sciences Reports Third Quarter 2012 Financial Results

[at noodls] – -Net Sales up 24%, Advanced Wound Care Sales up 67%, Traditional Wound Care Sales up 9%- -DSC127 Drug Program on Track for Phase 3 Start by Year End- Conference call begins at 11:00 a.m. Eastern time today … more

View todays social media effects on DSCI

View the latest stocks trending across Twitter. Click to view dashboard